Harkness Pharmaceuticals' Series A Round

Harkness Pharmaceuticals raised a round of funding on October 18, 2005. Investors include Sanderling Ventures.

Harkness Pharmaceuticals is focused on developing anti-obesity therapeutics. Per the company, currently more than 20% of the U.S. population are considered clinically obese yet there remain few thera…

Articles about Harkness Pharmaceuticals' Series A Round: